542650 Stock Overview
Metropolis Healthcare Limited provides diagnostic services in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Metropolis Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,793.15 |
| 52 Week High | ₹1,935.00 |
| 52 Week Low | ₹1,209.25 |
| Beta | 0.30 |
| 1 Month Change | 11.83% |
| 3 Month Change | 13.49% |
| 1 Year Change | 45.21% |
| 3 Year Change | -23.25% |
| 5 Year Change | 89.58% |
| Change since IPO | 86.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542650 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0.9% | -3.7% | -1.6% |
| 1Y | 45.2% | 62.3% | 45.0% |
Return vs Industry: 542650 underperformed the Indian Healthcare industry which returned 62.3% over the past year.
Return vs Market: 542650 matched the Indian Market which returned 45% over the past year.
Price Volatility
| 542650 volatility | |
|---|---|
| 542650 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 542650 has not had significant price volatility in the past 3 months.
Volatility Over Time: 542650's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 4,300 | Surendran Chemmenkotil | www.metropolisindia.com |
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates.
Metropolis Healthcare Limited Fundamentals Summary
| 542650 fundamental statistics | |
|---|---|
| Market cap | ₹91.68b |
| Earnings (TTM) | ₹1.25b |
| Revenue (TTM) | ₹11.59b |
73.5x
P/E Ratio7.9x
P/S RatioIs 542650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542650 income statement (TTM) | |
|---|---|
| Revenue | ₹11.59b |
| Cost of Revenue | ₹2.56b |
| Gross Profit | ₹9.03b |
| Other Expenses | ₹7.79b |
| Earnings | ₹1.25b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 24.35 |
| Gross Margin | 77.94% |
| Net Profit Margin | 10.76% |
| Debt/Equity Ratio | 22.0% |
How did 542650 perform over the long term?
See historical performance and comparison